LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Collaborations Dren Bio, Inc. has established a strategic collaboration with Novartis for developing novel Targeted Myeloid engagers for cancer. This partnership presents a sales opportunity to leverage the credibility of working with a major player in the pharmaceutical industry.

Revenue Growth Potential Recent financing of $150M in equity investment, with an upfront payment of $150 million, including $25 million from Novartis, indicates strong financial backing. This infusion of funds positions Dren Bio for potential revenue growth and opens doors for increased sales activities.

Key Personnel Appointment Amit Mehta was appointed as the Chief Operating Officer and Chief Business Officer at Dren Bio, Inc. His role in expanding the leadership team signifies a focus on operational and business aspects, indicating potential sales strategies led by experienced personnel.

Focus on Bispecific Antibodies Dren Bio, Inc. is actively developing bispecific antibodies for cancer, evident from a $3 billion agreement with Novartis Pharma. This specialization in cutting-edge treatments presents an attractive sales opportunity within the oncology market.

C-Level Movements Dr. Will, former Chief Medical Officer at Dren Bio, Inc., has joined Autolus. This transition highlights potential sales outreach to the network and connections of Dr. Will, leveraging relationships for business development opportunities.

Similar companies to Dren Bio, Inc.

Dren Bio, Inc. Tech Stack

Dren Bio, Inc. uses 8 technology products and services including cdnjs, Font Awesome, Ionicons, and more. Explore Dren Bio, Inc.'s tech stack below.

  • cdnjs
    Content Delivery Network
  • Font Awesome
    Font Scripts
  • Ionicons
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Highlight.js
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Adobe Creative Suite
    Visualisation Software

Media & News

Dren Bio, Inc.'s Email Address Formats

Dren Bio, Inc. uses at least 1 format(s):
Dren Bio, Inc. Email FormatsExamplePercentage
FLast@drenbio.comJDoe@drenbio.com
50%
FLast@drenbio.comJDoe@drenbio.com
50%

Frequently Asked Questions

Where is Dren Bio, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s main headquarters is located at 384 Foster City Blvd Foster City, California 94404 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is Dren Bio, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s official website is drenbio.com and has social profiles on LinkedIn.

How much revenue does Dren Bio, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc.'s annual revenue reached $3.8M.

What is Dren Bio, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dren Bio, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc. has approximately 74 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: N. T.Chief Operating Officer And Chief Business Officer: A. M.Chief Medical Officer: M. W.. Explore Dren Bio, Inc.'s employee directory with LeadIQ.

What industry does Dren Bio, Inc. belong to?

Minus sign iconPlus sign icon
Dren Bio, Inc. operates in the Biotechnology Research industry.

What technology does Dren Bio, Inc. use?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s tech stack includes cdnjsFont AwesomeIoniconsjQuery MigratejQueryHighlight.jsOWL CarouselAdobe Creative Suite.

What is Dren Bio, Inc.'s email format?

Minus sign iconPlus sign icon
Dren Bio, Inc.'s email format typically follows the pattern of . Find more Dren Bio, Inc. email formats with LeadIQ.

How much funding has Dren Bio, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Dren Bio, Inc. has raised $25M in funding. The last funding round occurred on Jul 24, 2024 for $25M.
Dren Bio, Inc.

Dren Bio, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

Dren Bio is a Foster City, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.

Section iconCompany Overview

Headquarters
384 Foster City Blvd Foster City, California 94404 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $25M

    Dren Bio, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jul 24, 2024 in the amount of $25M.

  • $10M

    Dren Bio, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $25M

    Dren Bio, Inc. has raised a total of $25M of funding over 5 rounds. Their latest funding round was raised on Jul 24, 2024 in the amount of $25M.

  • $10M

    Dren Bio, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.